Reported 3 days ago
Benchmark's Mark Palmer has assigned a buy rating to Semler Scientific (SMLR) with a price target of $101, highlighting the company's strategic shift from medical diagnostics to accumulating bitcoin as a treasury reserve. Since adopting bitcoin in May of last year, Semler has acquired approximately 4,636 BTC for $430 million. Despite a stock rally of 178% post-announcement, it still trades at a discount compared to peers. The company aims to accumulate 10,000 BTC by the end of 2025 and has a positive outlook if it can resolve ongoing legal challenges.
Source: YAHOO